They've already chose their identity
Krishna Vyas, a plastic surgeon in New York City, noted that under current conditions, the use of GLP-1 medications is "too limited, too uneven and too short-lived to meaningfully lower average passenger weight at a population level." "Most patients discontinue therapy within one to two years, and weight regain after stopping treatment is common, making durable, large-scale reductions in passenger mass unlikely," he told Fox News Digital
The participants' anxiety was assessed via self-report
We have subsequently updated the quality performance standard and reporting requirements through rulemaking in the CYs 2022, 2023, 2024, and 2025 PFS final rules (86 FR 65255 through 65272, 87 FR 69860 through 69863, 88 FR 79112 through 79114, and 89 FR 98101 through 98132, respectively)